for the year ended December 31, 2022, which details are as following; Operating results (Consolidated) Y2022 Y2021 % Increase (Decrease) Million Baht % Million Baht % Million Baht % Revenue from sales
dialysate and medical supply manufacturing and distribution, which increased from the same period of the previous year for 5.31 million baht or 22.37%, resulting in the increase of the Company Group’s gross
following details. Financial performance Statement of income Consolidated financial statements for the year 2016 2017 Change (Audited) (Audited) Increase (Decrease) THB Million % THB Million % THB Million
September 30, 2020, resulted in increase in Net Profit of Baht 63.26 million or +2,450.52% from the corresponding period of the previous year as the following details below: 1. Revenue from sales and services
5.09 million, representing an average increase of 0.70 million or an increase of 13.66%. The main reason for the decline in user spending was the infla- tionary situation of the country's economy
increase average revenue per household (ARPH) and ease pressure on ARPU as well as maintain pricing gap from competition. Enterprise business is anticipated to continue delivering double digit growth
generated total revenues of 1,093 million Baht; or decreasing by 49% as compared to the total revenues in Q3 2017 of 2,132 million Baht. This was mainly due to the increase in revenue from sales of the
7.37% and 10.80% from the previous year. The sales were impacted by several economic factors as well as the enforcement of the business shutdown order. As a result, the sales growth in this quarter did
6661 Fax: +662 661 6664 1 2019 IVL Performance Summary IVL registered volume growth of 18% in 2019 driven mainly by inorganic expansion. Industry-wide spreads declined to historical lows in 2019, leading
Comprehensive Income – Consolidated (Million Baht) For -month period ended June , Increase (Decrease) % For 6-month period ended June , Increase (Decrease) % 2020 2019 2020 2019 Revenues from sales and services